Recordati reported EUR485.55M in Operating Expenses for its fiscal quarter ending in September of 2026.





Operating Expenses Change Date
Almirall EUR 531.16M 13.76M Jun/2026
GlaxoSmithKline GBP 6.03B 227M Sep/2026
Hikma Pharmaceutical USD 1.34B 702M Dec/2025
Orion EUR 332.3M 12.7M Sep/2026
Sanofi EUR 10.51B 598M Sep/2026